Shockwave Medical (SWAV) reported Q3 EPS of $0.92, $0.39 better than the analyst estimate of $0.53. Revenue for the quarter came in at $131.3 million versus the consensus estimate of $123.97 million.
GUIDANCE:
Shockwave Medical sees Q4 2022 revenue of $483-488 million, versus the consensus of $475.94 million.